echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Eur Radiol: Can only PET be used for screening of bone metastases in middle and high-risk prostate cancer?

    Eur Radiol: Can only PET be used for screening of bone metastases in middle and high-risk prostate cancer?

    • Last Update: 2021-03-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The identification of bone metastases of prostate cancer is of great significance to the selection of appropriate treatment methods.


    Bone metastasis of prostate cancer usually occurs first in the pelvis, and then rises and develops in the axial bones and lymph nodes.



    Recently, a study published in the journal European Radiology evaluated the incidence and distribution of bone metastases in untreated prostate cancer patients using whole-body MRI for metastatic examination, and evaluated the results according to current guidelines.


    This study is a single-institution retrospective study that included all untreated prostate cancer patients from 2016 to 2017, and each patient underwent a full-body MRI examination.


    This study included 161 newly diagnosed prostate cancer patients, of which 36 (22%) were at moderate risk and 125 (78%) were at high risk.


    diagnosis

    Figure 56-year-old patient, PSA is 33 ng/ml, Gleason grade 4.


    This study shows that the overall incidence of bone metastases is very low according to current screening guidelines.


    This study shows that the overall incidence of bone metastases is very low according to current screening guidelines.


    Original source:

    Fredrik Ottosson,Eduard Baco,Peter M Lauritzen,et al.


    Fredrik Ottosson,Eduard Baco,Peter M Lauritzen,et al.
    The prevalence and locations of bone metastases using whole-body MRI in treatment-naïve intermediate- and high-risk prostate cancer.
    DOI: org/10.
    1007/s00330-020-07363-x">10.
    1007/s00330-020-07363-xorg/10.
    1007/s00330-020-07363-x"> 10.
    1007 /s00330-020-07363-x leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.